Franklin Biotechnology Discovery Fund

Portfolio Statistics

Assets

Total Fund AssetsAs of 08/31/2020 (updated monthly) $1,376.9 (M)
Net Assets - Class C As of 08/31/2020 (updated monthly) $58.8 (M)

Positions As of 08/31/2020

Equity VS. NASDAQ Biotechnology Index

Fund Benchmark
Market CapitalizationAs of 08/31/2020 (updated monthly) $31,449.49(M) $39,991.85(M)
P/B RatioAs of 08/31/2020 (updated monthly) 6.38 5.66
P/E Ratio (12-mo Forward)As of 08/31/2020 (updated monthly) 16.58 16.21
Price to Cash FlowAs of 08/31/2020 (updated monthly) 18.22 16.32

Portfolio Details

Asset AllocationAs of 08/31/2020

[name] [value]
Equity 94.59%
Cash & Cash Equivalents 5.41%

Geographic BreakdownAs of 08/31/2020

[name] [value]
United States 83.43%
Cash & Cash Equivalents 5.41%
United Kingdom 3.43%
Netherlands 2.81%
Denmark 2.28%
Canada 1.51%
Switzerland 1.13%

sector breakdownAs of 08/31/2020

[name] [value]
Biotechnology 77.69%
Pharmaceuticals 10.97%
Cash & Cash Equivalents 5.41%
Life Sciences Tools & Services 4.57%
Diversified Capital Markets 0.87%
Other Diversified Financial Services 0.28%
Health Care Equipment 0.22%

TOP TEN HOLDINGSAs of 08/31/2020

Issuer Country Industry % of total
REGENERON PHARMACEUTICALS INC United States Pharmaceuticals, Biotechnology & Life Sciences 6.91%
VERTEX PHARMACEUTICALS INC United States Pharmaceuticals, Biotechnology & Life Sciences 6.82%
AMGEN INC United States Pharmaceuticals, Biotechnology & Life Sciences 5.86%
ILLUMINA INC United States Pharmaceuticals, Biotechnology & Life Sciences 4.57%
BIOGEN INC United States Pharmaceuticals, Biotechnology & Life Sciences 3.95%
IMMUNOMEDICS INC United States Pharmaceuticals, Biotechnology & Life Sciences 3.90%
GILEAD SCIENCES INC United States Pharmaceuticals, Biotechnology & Life Sciences 3.89%
IOVANCE BIOTHERAPEUTICS INC United States Pharmaceuticals, Biotechnology & Life Sciences 3.43%
GW PHARMACEUTICALS PLC United Kingdom Pharmaceuticals, Biotechnology & Life Sciences 3.18%
NOVAVAX INC United States Pharmaceuticals, Biotechnology & Life Sciences 2.89%

Market Capitalization BreakdownAs of 08/31/2020

[name] [value]
<2.0 Billion 17.88%
2.0-5.0 Billion 20.74%
5.0-10.0 Billion 11.42%
10.0-25.0 Billion 13.05%
25.0-50.0 Billion 6.46%
>50.0 Billion 29.66%
N/A 0.79%